IMM 1.72% 29.5¢ immutep limited

recruitment for can003 trial phase, page-37

  1. 1,770 Posts.
    "....Can someone run a screen and tell me all the other companies with prominent scientists conducting PIII trials so I can invest?"

    Hypetastic, re above, don't be lazy - do it yourself.
    We holders have done our homework and are more than happy with what the company has achieved to date.

    Great product. Great Management. Great scientific team.

    There is one thing that I will do for you. I will, again, refer you to the following post from boiler.

    "The FDA approval for Phase 3 has been granted as per the entry on the ClinicalTrials.gov website, date of entry January 29, 2012. Marty will make an announcement to the market to confirm this significant milestone for Prima. The market needs to wake up and realise that the approval means that phase 2b is a success otherwise we wouldn't be running with an FDA approved Phase 3 trial, Hello any one home".

 
watchlist Created with Sketch. Add IMM (ASX) to my watchlist
(20min delay)
Last
29.5¢
Change
0.005(1.72%)
Mkt cap ! $428.5M
Open High Low Value Volume
28.5¢ 30.5¢ 28.5¢ $469.8K 1.579M

Buyers (Bids)

No. Vol. Price($)
9 297652 29.0¢
 

Sellers (Offers)

Price($) Vol. No.
30.0¢ 7500 2
View Market Depth
Last trade - 16.10pm 19/07/2024 (20 minute delay) ?
IMM (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.